FENTON, Mo. (KMOX) – As a post-tsumani nuclear crisis looms in Japan, concerns are stretching half way around the globe to the St. Louis area.
Quoting a Wall Street Journal article, the St. Louis Business Journal reports Wednesday that fear of radiation exposure from those damaged nuclear plants has created a spike in U.S. demand for potassium iodide.
That includes products made at Fenton-based Fleming Pharmaceuticals.
They expect to run out of their supply of ThyroShield sometime this week, and they’re fractically trying to ramp up production.
ThyroShield is a liquid medicine that sells for about $13 per 45-millileter bottle, and is designed for use in “radiation emergencies”.
Meanwhile, health officials are stressing that Japan’s nuclear worries currently pose no threat to U.S. citizens in an effort to stop the run on the product here at home.
Copyright KMOX Radio